SPR Therapeutics

OverviewSuggest Edit

SPR Therapeutics is a medical device company, which engages in developing and commercializing interventional pain management therapies. The Company develops Smartpatch, a percutaneous peripheral nerve stimulation (PNS) system for post-surgical pain following surgeries, such as knee replacement, thoracotomy, and rotator cuff repair; neuropathic pain, including pain following nerve injury, as well as nerve surgery, such as phantom limb pain; and musculoskeletal pains, such as shoulder and knee pains. It offers Smartpatch short-term therapy for sustained relief; Micropulse long term therapy through implantable PNS system; and Smartpatch MicroLead, which includes a coiled wire construction that fosters rapid tissue ingrowth.

TypePrivate
Founded2009
HQBeachwood, OH, US
Websitesprtherapeutics.com
Overall CultureB

Latest Updates

Employees (est.) (Sept 2021)93(+9%)
Cybersecurity ratingAMore

Key People/Management at SPR Therapeutics

Maria E. Bennett

Maria E. Bennett

President, CEO and Founder
David Youngberg

David Youngberg

Vice President, Sales
Mark Stultz

Mark Stultz

Senior Vice President, Market Development
Joseph Boggs

Joseph Boggs

Chief Scientific Officer
Warren Grill

Warren Grill

Chief Scientific Advisor
Peter Staats

Peter Staats

Chief Medical Advisor
Show more

SPR Therapeutics Office Locations

SPR Therapeutics has an office in Beachwood
Beachwood, OH, US (HQ)
22901 Millcreek Blvd #110
Show all (1)

SPR Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2009

SPR Therapeutics total Funding

$33.7 m

SPR Therapeutics latest funding size

$25 m

Time since last funding

4 years ago

SPR Therapeutics investors

SPR Therapeutics's latest funding round in September 2017 was reported to be $25 m. In total, SPR Therapeutics has raised $33.7 m
Show all financial metrics

SPR Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

SPR Therapeutics Online and Social Media Presence

Embed Graph

SPR Therapeutics Company Culture

  • Overall Culture

    B

    77/100

  • CEO Rating

    B+

    75/100

  • Compensation

    C+

    70/100

Learn more on Comparably

SPR Therapeutics News and Updates

SPR Therapeutics CEO Maria Bennett Selected as Winner of EY Entrepreneur of the Year in East Central Region

CLEVELAND, Aug. 06, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics is proud to announce that President, Founder and CEO Maria Bennett has been selected as an Ernst & Young (EY) Entrepreneur Of The Year® 2021 East Central Award winner. Bennett was selected from a prestigious list of finalists in the…

SPR Therapeutics Blogs

Virtual Event: ASRA Persistent Perioperative Pain Symposium

SPR Therapeutics is excited to be part of a special one-day only event from the American Society of Regional Anesthesia and Pain Medicine (ASRA), the Persistent Perioperative Pain Symposium virtual … The post Virtual Event: ASRA Persistent Perioperative Pain Symposium appeared first on SPR Therapeut…

Virtual Event: 45th Annual Scientific Meeting – Midwest Pain Society

SPR Therapeutics is pleased to be part of the 45th Annual Scientific Meeting of the Midwest Pain Society held virtually on September 25. The meeting will focus on addressing injustices … The post Virtual Event: 45th Annual Scientific Meeting – Midwest Pain Society appeared first on SPR Therapeutics.

Pain Awareness Month: 13 Facts About Pain and How it Can Affect Your Health

Nearly 20 percent (50.2 million) of Americans suffer from chronic pain according to a recent report by the Centers for Disease Control and Prevention (CDC). In conjunction with Pain Awareness … The post Pain Awareness Month: 13 Facts About Pain and How it Can Affect Your Health appeared first on SPR…

Survey of Chronic Low-back Pain Patients Indicates Clear Preference for Temporary, Non-destructive Treatment Options

Peripheral Nerve Stimulation Most Preferred Option Versus Radiofrequency  Ablation (RFA) or Permanently Implanted Stimulation   Cleveland, Ohio- September 22, 2021- Publication of a first of its kind patient preference survey … The post Survey of Chronic Low-back Pain Patients Indicates Clear Prefer…

SPRINT PNS System for Chronic Back Pain Relief

Chronic low back pain (LBP) is currently the second leading cause of disability in the United States, affecting approximately 10 percent of the population. Chronic low back pain is linked … The post SPRINT PNS System for Chronic Back Pain Relief appeared first on SPR Therapeutics.

Try New Postoperative Knee Pain Treatment in On-Going Study

Following orthopedic surgery, pain commonly prevents people from returning to their normal lives. Examples of orthopedic surgery include bone fracture repair, amputation, and joint replacement such as a total knee … The post Try New Postoperative Knee Pain Treatment in On-Going Study appeared first …
Show more

SPR Therapeutics Frequently Asked Questions

  • When was SPR Therapeutics founded?

    SPR Therapeutics was founded in 2009.

  • Who are SPR Therapeutics key executives?

    SPR Therapeutics's key executives are Maria E. Bennett, David Youngberg and Mark Stultz.

  • How many employees does SPR Therapeutics have?

    SPR Therapeutics has 93 employees.

  • Who are SPR Therapeutics competitors?

    Competitors of SPR Therapeutics include TEMA SINERGIE, Acelity and BSN Medical.

  • Where is SPR Therapeutics headquarters?

    SPR Therapeutics headquarters is located at 22901 Millcreek Blvd #110, Beachwood.

  • Where are SPR Therapeutics offices?

    SPR Therapeutics has an office in Beachwood.

  • How many offices does SPR Therapeutics have?

    SPR Therapeutics has 1 office.